| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 48.789 | 45.498 | 12.395 | 66.242 | 89.643 | 91.840 | 102.347 | 129.883 |
| Total Income - EUR | - | - | 48.789 | 45.498 | 12.395 | 66.242 | 89.643 | 91.840 | 102.347 | 129.883 |
| Total Expenses - EUR | - | - | 1.004 | 2.089 | 2.633 | 2.519 | 9.182 | 9.401 | 10.418 | 13.936 |
| Gross Profit/Loss - EUR | - | - | 47.785 | 43.409 | 9.762 | 63.723 | 80.461 | 82.440 | 91.929 | 115.946 |
| Net Profit/Loss - EUR | - | - | 46.321 | 42.044 | 9.390 | 61.877 | 79.565 | 81.588 | 90.926 | 112.148 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Evagyn Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 146 | 731 | 228 | 462 | 194 | 0 | 0 | 0 |
| Current Assets | - | - | 46.722 | 41.826 | 14.452 | 62.673 | 81.006 | 82.966 | 91.783 | 143.809 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.108 | 1.318 | 3.283 | 50.720 | 67.551 | 66.625 | 77.148 | 91.043 |
| Cash | - | - | 44.614 | 40.508 | 11.169 | 11.953 | 13.455 | 16.341 | 14.635 | 52.766 |
| Shareholders Funds | - | - | 46.365 | 42.096 | 9.441 | 61.926 | 79.613 | 81.637 | 90.974 | 112.196 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 467 | 461 | 5.240 | 1.208 | 1.586 | 1.329 | 1.653 | 31.613 |
| Income in Advance | - | - | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Evagyn Medical Srl